The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
Open accessAbstract
Dietary exposure to aflatoxin B(1) (AFB(1)) is associated with an increased incidence of hepatocellular carcinoma (HCC), especially in populations in which exposure to hepatitis B virus (HBV) is a common occurrence. Most HCC samples from people living where HBV is prevalent have one striking mutational hotspot: a GC-->TA transversion at the third position of codon 249 of the p53 gene. In this review, the chemical reaction of an electrophilic derivative of aflatoxin with specific DNA sequences is examined, along with the types of mutations caused by AFB(1) and the sequence context dependence of those mutations. An attempt is made to assign the source of these mutations to specific chemical forms of AFB(1)-DNA damage. In addition, epidemiological and experimental data are examined regarding the synergistic effects of AFB(1) and HBV on HCC formation and the predominance of one hotspot GC-->TA transversion in the p53 gene of affected individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., van Boom, J. H., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Miller, E. C. (1978) · PubMed · Cited by 932
MUTAGENESIS BY APURINIC/APYRIMIDINIC SITES
Loeb, L. A., & Preston, B. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.001221 · Cited by 901
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6264 · Cited by 614
Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.934 · Cited by 538
Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
Essigmann, J. M., Croy, R. G., Nadzan, A. M., Busby, W. F., Reinhold, V. N., Büchi, G., & Wogan, G. N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.1870 · Cited by 507
Self-citationAguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress
Amundson, S. A., Myers, T. G., & Fornace, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202576 · Cited by 424
Cytosine methylation determines hot spots of DNA damage in the human P 53 gene
Denissenko, M. F., Chen, J. X., Tang, M.-S., & Pfeifer, G. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3893 · Cited by 339
Wang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.347 · Cited by 307
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Base substitution mutations induced by metabolically activated aflatoxin B1.
Foster, P. L., Eisenstadt, E., & Miller, J. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2695 · Cited by 274
Puisieux, A., Lim, S.-K., Groopman, J. D., & Öztürk, M. (1991) · PubMed · Cited by 259
Truant, R., Antunovic, J., Greenblatt, J., Prives, C., & Cromlish, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1851-1859.1995 · Cited by 255
Lin, J., MILLER, J. A., & Miller, E. C. (1977) · PubMed · Cited by 253
Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.
Croy, R. G., Essigmann, J. M., Reinhold, V. N., & Wogan, G. N. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1745 · Cited by 250
Self-citationSunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases.
Tommasi, S., Denissenko, M. F., & Pfeifer, G. P. (1997) · PubMed · Cited by 236
Mace, K. (1997) · Carcinogenesis · doi:10.1093/carcin/18.7.1291 · Cited by 224
Interaction of p53 with the Human Rad51 Protein
Buchhop, S., Gibson, M. K., Wang, X. W., Wagner, P., Sturzbecher, H.-W., & Harris, C. C. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.19.3868 · Cited by 215
Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector
Lawrence, C. W., Borden, A., Banerjee, S. K., & LeClerc, J. E. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.8.2153 · Cited by 199
Maxwell, A., & Critchlow, S. E. (1998) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-80364-2_4 · Cited by 197
p53-Dependent cell cycle control: response to genotoxic stress
Schwartz, D., & Rotter, V. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0095 · Cited by 195
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
Kirk, G. D., Camus-Randon, A.-M., Mendy, M., Goedert, J. J., Merle, P., Trépo, C., Bréchot, C., Hainaut, P., & Montesano, R. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.148 · Cited by 190
Introduction: p53 – the first twenty years
Oren, M., & Rotter, V. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050265 · Cited by 180
Basu, A. K., & Essigmann, J. M. (1988) · Chemical Research in Toxicology · doi:10.1021/tx00001a001 · Cited by 179
Self-citationThe dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 176
Elevated Aflatoxin Exposure and Increased Risk of Hepatocellular Carcinoma
Chen, C.-J., Wang, L.-Y., Lu, S.-N., Wu, M.-H., You, S.-L., Zhang, Y.-J., Wang, L.-W., & Santella, R. M. (1996) · Hepatology · doi:10.1002/hep.510240108 · Cited by 173
Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
Shen, H.-M., & Ong, C.-N. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90005-6 · Cited by 171
Lunn, R. M., Zhang, Y. J., Wang, L., Chen, C., Lee, P., Lee, C. S., Tsai, W. Y., & Santella, R. M. (1997) · PubMed · Cited by 170
Hepatitis B virus X protein inhibits nucleotide excision repair
Jia, L., Wang, X. W., & Harris, C. C. (1999) · International Journal of Cancer · Cited by 169
Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey, E. A., Iyer, R. S., Stone, M. P., Harris, T. M., & Essigmann, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1535 · Cited by 165
Self-citationCarcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.
Chen, J. X., Zheng, Y., West, M., & Tang, M. (1998) · PubMed · Cited by 164
Environmental and genetic determinants of aflatoxin-albumin adducts in The Gambia
Wild, C. P., Yin, F., Turner, P. C., Chemin, I., Chapot, B., Mendy, M., Whittle, H., Kirk, G. D., & Hall, A. J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<1::aid-ijc1>3.0.co;2-i · Cited by 160
In vitro reactions of aflatoxin B1-adducted DNA.
Groopman, J. D., Croy, R. G., & Wogan, G. N. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5445 · Cited by 139
Johnson, W. W., & Guengerich, F. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6121 · Cited by 134
Transcriptional repression of the human p53 gene by hepatitis B viral X protein
Lee, S., & Rho, H. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203312 · Cited by 127
Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
McMahon, G., Davis, E. F., Huber, L. J., Kim, Y., & Wogan, G. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1104 · Cited by 125
Sequence specificity in aflatoxin B1--DNA interactions.
Muench, K. F., Misra, R. P., & Humayun, M. Z. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.6 · Cited by 122
Mutagenicity of a unique apurinic/apyrimidinic site in mammalian cells
Gentil, A., Cabral-Neto, J. B., Mariage, R., Margot, A., Imbach, J. L., Rayner, B., & Sarasin, A. R. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90513-j · Cited by 109
Benasutti, M., Ejadi, S., Whitlow, M. D., & Loechler, E. L. (1988) · Biochemistry · doi:10.1021/bi00401a068 · Cited by 106
Overexpression of the Bcl-2 Protein Increases the Half-life of p21Bax
Miyashita, T., Kitada, S., Krajewski, S., Horne, W. A., Delia, D., & Reed, J. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26049 · Cited by 105
Denissenko, M. F., Koudriakova, T. B., Smith, L. G., O'Connor, T. R., Riggs, A. D., & Pfeifer, G. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202214 · Cited by 104
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
Forrester, K., Lupold, S. E., Ott, V. L., Chay, C. H., Band, V., Wang, X. W., & Harris, C. C. (1995) · PubMed · Cited by 100
Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.
McMahon, G., Hanson, L., Lee, J. J., & Wogan, G. N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9418 · Cited by 97
Levy, D. D., Groopman, J. D., Lim, S. E., Seidman, M. M., & Kraemer, K. H. (1992) · Cancer Research · Cited by 92
D’Andrea, A. D., & Haseltine, W. A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4120 · Cited by 90
Vautier, G., Bomford, A. B., Portmann, B. C., Metivier, E. M., Williams, R. L., & Ryder, S. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70562-7 · Cited by 88
Rashid, A., Wang, J.-S., Qian, G.-S., Lu, B.-X., Hamilton, S. R., & Groopman, J. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690321 · Cited by 87
Gopalakrishnan, S., Harris, T. M., & Stone, M. P. (1990) · Biochemistry · doi:10.1021/bi00498a002 · Cited by 85
Reconstitution of Human Base Excision Repair with Purified Proteins
Nicholl, I. D., Nealon, K., & Kenny, M. K. (1997) · Biochemistry · doi:10.1021/bi962950w · Cited by 83
Yanagimoto, T., Itoh, S., Sawada, M., & Kamataki, T. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9900 · Cited by 73
Mutagenesis by apurinic sites in normal and ataxia telangiectasia human lymphoblastoid cells
Klinedinst, D. K., & Drinkwater, N. R. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060107 · Cited by 71
Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
Fujimoto, Y., Hampton, L. L., Luo, L., Wirth, P. J., & Thorgeirsson, S. S. (1992) · PubMed · Cited by 67
Denissenko, M. F., Cahill, J. M., Koudriakova, T. B., Gerber, N., & Pfeifer, G. P. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00038-x · Cited by 66
Soman, N. R., & Wogan, G. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2045 · Cited by 66
Sohn, S. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00010-0 · Cited by 65
Yan, R. Q., Su, J. J., Huang, D. R., et al. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01261405 · Cited by 61
Apurinic sites cause mutations in simian virus 40
Gentil, A., Margot, A., & Sarasin, A. R. (1984) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(84)90146-5 · Cited by 60
Ghebranious, N., & Sell, S. (1998) · Hepatology · doi:10.1002/hep.510270411 · Cited by 58
Dycaico, M. J., Stuart, G. R., Tobal, G. M., de Boer, J. G., Glickman, B. W., & Provost, G. S. L. (1996) · Carcinogenesis · doi:10.1093/carcin/17.11.2347 · Cited by 58
p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus.
Puisieux, A., Ji, J., Guillot, C., Legros, Y., Soussi, T., Isselbacher, K. J., & Öztürk, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1342 · Cited by 57
Buetler, T. M., Stone, D., & Eaton, D. L. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91098-b · Cited by 53
Trottier, Y., Waithe, W. I., & Anderson, A. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060209 · Cited by 51
Park, U. S., Su, J. J., Ban, K. C., et al. (2000) · Gene · doi:10.1016/s0378-1119(00)00183-9 · Cited by 50
Tang, M. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1085 · Cited by 47
Yu, F. (1983) · Carcinogenesis · doi:10.1093/carcin/4.7.889 · Cited by 44
Kamiya, H., Suzuki, M., Komatsu, Y., Miura, H., Kikuchi, K., Sakaguchi, T., Murata, N., Masutani, C., Hanaoka, F., & Ohtsuka, E. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.17.4409 · Cited by 43
Choisy, C., Reisdorf, P., & Yonish-Rouach, E. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00238-0 · Cited by 38
Schaefer, S., Gerlich, W. H., Fink, L., Seifer, M., Wenderhold, S., Grimmsmann, T., & H�hne, M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-4-767 · Cited by 33
Harris, A. J., Shaddock, J. G., Manjanatha, M. G., Lisenbey, J. A., & Casciano, D. A. (1998) · Carcinogenesis · doi:10.1093/carcin/19.8.1451 · Cited by 27
Chomarat, P., Rice, J. M., Slagle, B. L., & Wild, C. P. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00254-9 · Cited by 23
Rivkina, M., Cullen, J. M., Robinson, W. S., & Marion, P. L. (1994) · PubMed · Cited by 22
Cited by
Mechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039
Heme Enzyme Structure and Function
Poulos, T. L. (2014) · Chemical Reviews · doi:10.1021/cr400415k · Cited by 1,443
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action
Benkerroum, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020423 · Cited by 554
Bartsch, H., & Nair, J. (2006) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-006-0073-1 · Cited by 516
Metadata
- Authors
- Smela, M. E., Currier, S. S., Bailey, E. A., & Essigmann, J. M.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04
- Volume
- 22
- Issue
- 4
- Pages
- 535-545
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2093370229
- Cited by
- 362
- References
- 81
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.